Jean Lemoine

Title: The Innovative Contributions of Jean Lemoine

Introduction

Jean Lemoine is a notable inventor based in Garches, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of therapeutic agents. With a total of 5 patents to his name, Lemoine's work has had a considerable impact on medical science.

Latest Patents

Lemoine's latest patents include innovative compounds that serve important therapeutic functions. One of his notable inventions is related to derivatives of 3-amino-1-benzofuranyloxy-2-propanol, which are useful as cardioselective beta-blocking agents. This invention presents new industrial products, specifically the compounds of general formula: ##STR1## where R is CH(CH.sub.3).sub.2 or C(CH.sub.3).sub.3, along with their acid addition salts. Another significant patent involves an extract from the Globularia genus, such as Globularia alypum and Globularia vulgaris. This extract is recognized for its antibrucella, bacteriostatic, and antiphlogistic properties, making it valuable in both human and veterinary therapy, particularly for treating brucellosis.

Career Highlights

Throughout his career, Lemoine has worked with reputable companies, including Laboratoire Debat and Société Anonyme Dite: Laboratoire Debat. His work in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in therapeutic solutions.

Collaborations

Lemoine has collaborated with several professionals in his field, including Jacques Debat and Françoise Lier Nee Gabillault. These collaborations have fostered a creative environment that has led to the successful development of his patented inventions.

Conclusion

Jean Lemoine's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to advancing medical science. His work continues to influence therapeutic practices and improve patient care.